標記臨床研究 XOMA 深 滬
已收盤 08-08 16:00:00 美东时间
26.50
+0.660
+2.55%
華盛通- 最 高27.64
- 今 開25.80
- 成交量 3.89万股
- 最 低 25.68
- 昨 收 25.84
- 總市值 3.17亿
- 52周最高 35.00
- 市盈率 靜 --
- 換手率 0.32%
- 52周最低 18.352
- 委 比 33.33%
- 總股本 1196.69万
- 歷史最高 191.40
- 量 比 1.08
- 振 幅 7.59%
- 歷史最低 3.96
- 每 手 1
- 風險率 3.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders
NEW YORK, Aug. 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
08-05 00:23
LAVA Therapeutics Agrees to Acquisition by XOMA
The latest announcement is out from LAVA Therapeutics ( ($LVTX) ). On August 3,...
08-04 19:58
HilleVax Announces Merger Agreement with XOMA
An update from HilleVax, Inc ( ($HLVX) ) is now available. On August 4, 2025, H...
08-04 19:48
HilleVax to be acquired by XOMA Royalty
HilleVax (NASDAQ:HLVX) and XOMA Royalty (NASDAQ:XOMA) have entered into a definitive merger agreement, whereby XOMA Royalty will acquire all of the issued and outstanding common shares of HilleVax. ...
08-04 19:16
Xoma Royalty Agrees To Acquire HilleVax $1.95 In Cash Per Share Plus One Non-transferable Contingent Value Right
Under the terms of the Merger Agreement, HilleVax stockholders will receive $1.95 in cash per share of HilleVax common stock at the closing of the merger, plus one non-transferable contingent value right ("CVR"), which
08-04 19:03
XOMA Royalty To Acquire Turnstone Biologics For $0.34 Per Share Plus CVR In August-Targeted Merger Deal
Pursuant and subject to the terms of the Merger Agreement, XOMA Royalty will commence a tender offer (the "Offer") by July 11, 2025, to acquire all outstanding shares of Turnstone common stock. The closing of the
06-27 19:33
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
XOMA Royalty Corporation will acquire Turnstone Biologics Corp. for $0.34 in cash per share plus one non-transferable contingent value right (CVR). The deal, approved by Turnstone's board, involves a tender offer to acquire all outstanding shares, with closing expected in August 2025. Leerink Partners and Cooley LLP are advising Turnstone, while Gibson, Dunn & Crutcher LLP is advising XOMA Royalty. Turnstone stockholders holding ~25.2% of shares ...
06-27 11:30
XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
XOMA Corp - 8.375% DP PFD B (NASDAQ:XOMAO) declares $0.5234/share quarterly dividend, in line with previous. Forward yield 8.29% Payable July 15; for shareholders of record July 3; ex-div July 3. See ...
06-18 21:19
XOMA Preferred Shares Series A declares $0.539 dividend
XOMA Preferred Shares Series A (NASDAQ:XOMAP) declares $0.539/share quarterly dividend, in line with previous. Forward yield 8.41% Payable July 15; for shareholders of record July 3; ex-div July 3. Se...
06-18 21:19
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Corporation announced cash dividends on its Series A and Series B Cumulative Preferred Stock. Series A holders will receive $0.53906 per share, while Series B depositary shares will receive $0.52344 per share. Dividends will be paid on July 15, 2025, to holders of record as of July 3, 2025. XOMA Royalty is a biotechnology royalty aggregator focused on acquiring future economic rights from therapeutic candidates, helping biotech compa...
06-18 11:30
